Wave Life Sciences Ltd. (WVE) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $4.53 (+1.35%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 14, 2026 | Andrew Fein | H.C. Wainwright | $18.00 | +297.8% |
| Feb 2, 2026 | Michael Freeman | Raymond James | $26.00 | +474.6% |
| Dec 19, 2025 | Andrew Fein | H.C. Wainwright | $30.00 | +563.0% |
| Dec 16, 2025 | Cheng Li | Oppenheimer | $32.00 | +607.2% |
| Dec 12, 2025 | Yun Zhong | Wedbush | $33.00 | +629.3% |
| Dec 9, 2025 | Steve Seedhouse | Cantor Fitzgerald | $34.00 | +651.4% |
| Oct 27, 2025 | Steve Seedhouse | Cantor Fitzgerald | $12.00 | +165.2% |
| Sep 4, 2025 | Tiago Fauth | Wells Fargo | $18.00 | +297.8% |
| Nov 12, 2024 | Joon Leen | Truist Financial | $36.00 | +695.6% |
| Oct 21, 2024 | Luca Issi | RBC Capital | $15.00 | +231.5% |
| Oct 17, 2024 | Tiago Fauth | Wells Fargo | $22.00 | +386.2% |
| Oct 16, 2024 | Strong Buy | Raymond James | $22.00 | +386.2% |
| Oct 16, 2024 | Joseph Schwartz | Leerink Partners | $22.00 | +386.2% |
| Oct 3, 2024 | Madison El-Saadi | B.Riley Financial | $19.00 | +319.9% |
| Sep 25, 2024 | Salim Syed | Mizuho Securities | $19.00 | +319.9% |
| Sep 25, 2024 | Madison El-Saadi | B.Riley Financial | $11.00 | +143.1% |
| Jun 25, 2024 | Joon Leen | Truist Financial | $17.00 | +275.7% |
| May 15, 2024 | Tiago Fauth | Wells Fargo | $11.00 | +143.1% |
Top Analysts Covering WVE
WVE vs Sector & Market
| Metric | WVE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 13 | 8 | 18 |
| Target Upside | +206.0% | +16187.0% | +19.5% |
| P/E Ratio | -8.20 | 3.80 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $2M | $8M | $11M | 4 |
| 2026-12-31 | $2M | $9M | $12M | 8 |
| 2027-03-31 | $2M | $9M | $12M | 4 |
| 2027-06-30 | $2M | $9M | $12M | 4 |
| 2027-09-30 | $2M | $10M | $13M | 5 |
| 2027-12-31 | $6M | $26M | $35M | 4 |
| 2028-12-31 | $136M | $138M | $140M | 12 |
| 2029-12-31 | $57M | $300M | $528M | 11 |
| 2030-12-31 | $114M | $605M | $1.07B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.50 | $-0.35 | $0.00 | 3 |
| 2026-12-31 | $-0.51 | $-0.36 | $0.00 | 6 |
| 2027-03-31 | $-0.50 | $-0.35 | $0.00 | 3 |
| 2027-06-30 | $-0.58 | $-0.41 | $0.00 | 5 |
| 2027-09-30 | $-0.58 | $-0.41 | $0.00 | 3 |
| 2027-12-31 | $-0.53 | $-0.37 | $0.00 | 6 |
| 2028-12-31 | $-2.13 | $-1.23 | $-0.52 | 10 |
| 2029-12-31 | $-1.20 | $-0.60 | $0.03 | 4 |
| 2030-12-31 | $-0.02 | $0.30 | $0.60 | 4 |
Frequently Asked Questions
What is the analyst consensus for WVE?
The consensus among 13 analysts covering Wave Life Sciences Ltd. (WVE) is Buy with an average price target of $20.29.
What is the highest price target for WVE?
The highest price target for WVE is $36.00, set by Joon Leen at Truist Financial on 2024-11-12.
What is the lowest price target for WVE?
The lowest price target for WVE is $11.00, set by Tiago Fauth at Wells Fargo on 2024-05-15.
How many analysts cover WVE?
13 analysts have issued ratings for Wave Life Sciences Ltd. in the past 12 months.
Is WVE a buy or sell right now?
Based on 13 analyst ratings, WVE has a consensus rating of Buy (2.00/5) with a +206.0% upside to the consensus target of $20.29.
What are the earnings estimates for WVE?
Analysts estimate WVE will report EPS of $-0.35 for the period ending 2026-09-30, with revenue estimated at $8M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.